Cortisol Could Be the Next Frontier for Wearables

Neko Health raises $700M and heads to New York

Neko Health, Daniel Ek's body-scanning startup, raised $700M at nearly $7bn and is opening its first US clinic in New York, backed by A-listers.

The 6 best scar creams that complement today’s consumer beauty tech

A sponsored listicle covering six scar creams paired with consumer beauty technology such as ultrasonic infusion devices, LED light therapy wands, AI-powered skin tracking apps, wearable moisture sensors, and smart home ambient sensors. Each product is briefly described alongside a tech pairing that supposedly enhances its effectiveness.

CurifyLabs raises $14M to 3D-print personalised medicine

CurifyLabs, startup Phần Lan, huy động 14 triệu USD Series A để mở rộng nền tảng dược phẩm cá nhân hóa in 3D tại Mỹ. Hệ thống của họ kết hợp phần mềm, nguyên liệu dược phẩm đạt chuẩn và máy in 3D (PharmaPrinter Aurum, nhanh gấp 9 lần phương pháp thủ công, đạt chứng nhận ISO 13485) để tự động hóa bào chế thuốc theo đơn cá nhân. Số tiền này sẽ được dùng cho mở rộng tại Mỹ, chuỗi cung ứng, hỗ trợ khách hàng và nghiên cứu.

Nếu bạn đang tìm kiếm cách tự động hóa và tối ưu hóa quy trình phát triển thuốc cá nhân hóa, công nghệ 3D in thuốc của CurifyLabs sẽ giúp bạn hiểu rõ hơn về cách công nghệ tiên tiến đang thay đổi ngành y tế và tạo ra những giải pháp hiệu quả hơn trong tương lai.

ResMed sells its MatrixCare software business to Frazier for $490m

ResMed has agreed to sell its MatrixCare home-health and senior-care software business to private equity firm Frazier Healthcare Partners for $490m in cash. MatrixCare generated roughly $220m in revenue and $55m in non-GAAP operating profit in ResMed's 2026 fiscal year. The deal includes HealthcareFirst, Citus, and ResMed's home-health and hospice offerings, but excludes Brightree and MEDIFOX DAN. ResMed plans to use the proceeds for share buybacks, aligning with its 2030 strategy focused on sleep health, breathing health, and connected home care. The sale price — well below peak software multiples — reflects a more disciplined buyer market for health software assets.

Sleep Tracking, Bluetooth Signals, and EMF: What Every Wearable User Should Know

Sleep tracking wearables like the Oura Ring and Apple Watch use Bluetooth Low Energy (BLE), which transmits at 1–10 milliwatts — far below the power of a phone call and well within FCC and ICNIRP SAR safety limits. WHO-commissioned systematic reviews published in 2024–2025 found no causal link between RF-EMF exposure below safety thresholds and sleep disruption. A common mistake is citing ELF (50–60 Hz power line) melatonin studies to argue against 2.4 GHz Bluetooth devices — these are different parts of the spectrum with different biological interaction mechanisms. For those still concerned, enabling airplane or low-power mode at night reduces wireless transmissions while preserving most sensor-based tracking. The more significant risk from sleep trackers may actually be 'orthosomnia' — anxiety driven by obsessing over inaccurate sleep stage estimates that wearables infer from movement and heart rate rather than measure directly.